These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias. Burger H; Nooter K; Zaman GJ; Sonneveld P; van Wingerden KE; Oostrum RG; Stoter G Leukemia; 1994 Jun; 8(6):990-7. PubMed ID: 7911548 [TBL] [Abstract][Full Text] [Related]
27. [Immunophenotypes on blast cells of chronic myelogenous leukemia]. Motoji T Nihon Rinsho; 2001 Dec; 59(12):2342-7. PubMed ID: 11766336 [TBL] [Abstract][Full Text] [Related]
28. The abnormal p53 proteins expressed in CML cell lines are non-functional. Bi S; Lanza F; Goldman JM Leukemia; 1993 Nov; 7(11):1840-5. PubMed ID: 8231251 [TBL] [Abstract][Full Text] [Related]
29. The role of the MDR-1/P-170 mechanism in the development of multidrug resistance in chronic myeloid leukemia. Weide R; Dowding C; Paulsen W; Goldman J Leukemia; 1990 Oct; 4(10):695-9. PubMed ID: 1976871 [TBL] [Abstract][Full Text] [Related]
30. p53 protein expression in leukemias. Paydas S Acta Oncol; 1995; 34(1):23-6. PubMed ID: 7865230 [TBL] [Abstract][Full Text] [Related]
31. Studies of P-glycoprotein in chronic myelogenous leukaemia patients: expression, activity and correlations with CD34 antigen. Turkina AG; Baryshnikov AY; Sedyakhina NP; Folomeshkina SV; Sokolova MA; Choroshco ND; Stavrovskaya AA Br J Haematol; 1996 Jan; 92(1):88-96. PubMed ID: 8562416 [TBL] [Abstract][Full Text] [Related]
32. [Mutations of the p53 gene in hematologic neoplasms]. Mori N; Mizoguchi H Nihon Rinsho; 1992 Jun; 50(6):1353-7. PubMed ID: 1518157 [TBL] [Abstract][Full Text] [Related]
33. The role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia. List AF Leukemia; 1996 Apr; 10 Suppl 1():S36-8. PubMed ID: 8618469 [TBL] [Abstract][Full Text] [Related]
34. P-glycoprotein (P-170) expression in acute leukemias. Abd El-Ghaffar HA; Aladle DA; Farahat SE; Abd El-Hady N Hematology; 2006 Feb; 11(1):35-41. PubMed ID: 16522547 [TBL] [Abstract][Full Text] [Related]
35. Platelet enzyme abnormalities in leukemias. Sharma S; Purohit A; Pati HP; Kochupillai V Indian J Cancer; 2011; 48(3):323-7. PubMed ID: 21921332 [TBL] [Abstract][Full Text] [Related]
36. [Functional activity and expression of P-glycoprotein in chronic myeloid leukemia]. Stromskaia TP; Rybalkina EIu; Turkina AG; Zabotina TN; Logacheva NP; Zakharova ES; Mechetner EB; Baryshnikov AIu; Khoroshko ND; Stavrovskaia AA Ter Arkh; 2001; 73(7):20-5. PubMed ID: 11523404 [TBL] [Abstract][Full Text] [Related]
37. In acute myeloid leukemia, coexpression of at least two proteins, including P-glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat-shock protein 27, is predictive of the response to induction chemotherapy. Kasimir-Bauer S; Ottinger H; Meusers P; Beelen DW; Brittinger G; Seeber S; Scheulen ME Exp Hematol; 1998 Nov; 26(12):1111-7. PubMed ID: 9808049 [TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of curcumin on MDR1 gene expression in patient leukemic cells. Anuchapreeda S; Thanarattanakorn P; Sittipreechacharn S; Tima S; Chanarat P; Limtrakul P Arch Pharm Res; 2006 Oct; 29(10):866-73. PubMed ID: 17121181 [TBL] [Abstract][Full Text] [Related]
39. Expression of the multidrug resistance P glycoprotein in newly diagnosed adult acute lymphoblastic leukemia: absence of correlation with response to treatment. Wattel E; Lepelley P; Merlat A; Sartiaux C; Bauters F; Jouet JP; Fenaux P Leukemia; 1995 Nov; 9(11):1870-4. PubMed ID: 7475277 [TBL] [Abstract][Full Text] [Related]
40. [Multidrug resistance in chronic lymphocytic leukemia]. Szendrei T; Magyarlaki T; Kovács G; Nagy A; Szomor A; Molnár L; Dávid M; Tokés-Füzesi M; Rideg O; Pótó L; Pajor L; Kajtár B; Losonczy H Orv Hetil; 2008 Jan; 149(4):161-7. PubMed ID: 18201958 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]